Form Bio Co. Ltd. (377220) — Capital Reinvestment Ratio
Form Bio Co. Ltd. (377220) has a Capital Reinvestment Ratio of 3.43x as of September 2022, meaning it reinvests 3% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩10.55 Billion). Check Form Bio Co. Ltd. (377220) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Form Bio Co. Ltd. Capital Reinvestment Ratio (2019–2020)
This chart tracks Form Bio Co. Ltd.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see how efficiently does Form Bio Co. Ltd. generate cash.
Annual Capital Reinvestment Ratio for Form Bio Co. Ltd. (2019–2020)
Year-by-year Capital Reinvestment Ratio for Form Bio Co. Ltd. from 2019 to 2020. See 377220 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.42x | ₩15.61 Billion | ₩6.63 Billion | ▲ +5.6% |
| 2019 | 0.40x | ₩5.68 Billion | ₩2.28 Billion | — |